摘要 |
<p>Compounds of formula (I) that are used as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and /or viral production in a cell-based system. Wherein Z, R30, R40, R50 and R60 of compounds of formula (I) are herein defined as in the description.</p> |
申请人 |
MERCK SHARP & DOHME CORP.;MCCOMAS, CASEY CAMERON;LIVERTON, NIGEL J.;SOLL, RICHARD;LI, PENG;PENG, XUANJIA;WU, HAO |
发明人 |
MCCOMAS, CASEY CAMERON;LIVERTON, NIGEL J.;SOLL, RICHARD;LI, PENG;PENG, XUANJIA;WU, HAO |